Engineering unactivated platelets for targeted drug delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Hematology

Background:

• Platelets are essential blood components involved in hemostasis, vascular integrity, inflammation, and immune responses.
• Their unique biological characteristics make them suitable candidates for drug delivery applications.
• Recent advancements facilitate the creation of engineered platelets using diverse techniques.

Purpose of the Study:

• To review recent progress in utilizing unactivated platelets as drug delivery vehicles.
• To summarize construction strategies for engineered platelets.
• To discuss the therapeutic potential and challenges of engineered platelets.

Main Methods:

• Internal loading of therapeutic agents into platelets.
• Surface modification of platelets for targeted delivery.
• Genetic engineering techniques to imbue platelets with specific functions.

Main Results:

• Engineered platelets can be constructed through various methods, including internal loading, surface modification, and genetic engineering.
• These engineered platelets show promise as platforms for immunotherapy and chemokine therapy.
• Potential applications span cardiovascular diseases, cancers, and infectious diseases.

Conclusions:

• Engineered platelets represent a promising drug delivery system with broad therapeutic potential.
• Further research is needed to address challenges in maintaining natural platelet activity in engineered forms.
• The development of engineered platelets could revolutionize treatment strategies for numerous diseases.